Genome British Columbia

LightIntegra Technology Inc. is a medical diagnostics company based in Vancouver, Canada, established in 2009. It specializes in developing innovative diagnostic solutions to enhance platelet quality and reduce complications associated with blood transfusions, particularly in cancer patients. The flagship product, ThromboLUX, is an in-vitro diagnostic test that delivers both qualitative and quantitative assessments of microparticle content in platelet samples. This rapid test identifies the size distribution of microparticles, which is critical for determining the suitability of platelet units for various medical applications, including prophylactic and therapeutic uses. Additionally, LightIntegra offers control kits and ThromboSight, a software tool that facilitates the analysis of test results. The company's technology leverages advancements in dynamic light scattering and laser optics to provide a safe, efficient, and straightforward diagnostic approach for evaluating platelet function and quality.

Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company aims to enhance routine liver health evaluation through non-invasive methods that provide reliable diagnostic accuracy. Its portable ultrasound devices are designed for point-of-care diagnostics and procedure guidance, enabling healthcare practitioners to improve the standard of care in quantifying conditions such as fatty liver disease. Through its innovative technology, Sonic Incytes seeks to facilitate better management of liver health for patients.

Developer of a wine barrel management technology designed to enhance production and analysis. The company's system allows barrel topping, sampling, sulfating and chemical analysis to occur in one interaction, all without ever opening the barrel, enabling wineries to simplify the process of barrel management and increase operational efficiencies.

Acuva Technologies Inc., founded in 2014 and based in Vancouver, Canada, specializes in the development of ultraviolet light-emitting diode (UV-LED) water purification systems. The company focuses on producing compact, modular, and scalable devices that target low to moderate volumes of water. Acuva's systems utilize short-wavelength UV radiation to effectively inactivate microorganisms, including viruses and bacteria, by disrupting their DNA and preventing vital cellular functions. This innovative technology ensures that users have access to safe and hygienic drinking water, addressing the growing demand for effective water treatment solutions.

Alavida Health Ltd. is a Vancouver-based company that specializes in alcohol treatment programs grounded in a cognitive-behavioral framework. The company has developed a digital health rehabilitation platform that addresses alcohol and substance use addiction through a comprehensive approach. Alavida's offerings include various treatment programs designed by professional therapists, which integrate targeted pharmacotherapy and motivational interviewing alongside cognitive behavioral therapy. This innovative solution aims to provide effective support for individuals seeking to overcome alcohol addiction.

Starling Minds Inc. provides digital mental health therapy. The company also offers disability management, treatment, and absence management services. It offers solutions in the areas of business, disability management, education, healthcare, insurance providers, and workers compensation. The company was founded in 2013 and is based in Vancouver, Canada.

LightIntegra Technology Inc. is a medical diagnostics company based in Vancouver, Canada, established in 2009. It specializes in developing innovative diagnostic solutions to enhance platelet quality and reduce complications associated with blood transfusions, particularly in cancer patients. The flagship product, ThromboLUX, is an in-vitro diagnostic test that delivers both qualitative and quantitative assessments of microparticle content in platelet samples. This rapid test identifies the size distribution of microparticles, which is critical for determining the suitability of platelet units for various medical applications, including prophylactic and therapeutic uses. Additionally, LightIntegra offers control kits and ThromboSight, a software tool that facilitates the analysis of test results. The company's technology leverages advancements in dynamic light scattering and laser optics to provide a safe, efficient, and straightforward diagnostic approach for evaluating platelet function and quality.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company develops advanced living tissues through its proprietary microfluidic 3D bioprinting platform. This technology allows for precise control over biomaterial composition and structure during tissue fabrication, facilitating research in areas such as respiratory diseases. Aspect also provides contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical companies and academic institutions. In addition to its core offerings, Aspect is advancing internal programs focused on regenerative medicine, particularly for metabolic diseases and musculoskeletal disorders, while collaborating with industry partners to commercialize bioprinted therapeutics.

Microbiome Insights, Inc. is a global leader providing end-to-end services for microbiome DNA sequencing, including state-of-the-art bioinformatic analysis. Based in Vancouver, Canada, the company's customized suite of services enables researchers and clinicians to easily and effectively include microbiome analysis in studies across a range of human, animal, agricultural and environmental applications. The multidisciplinary team of researchers and knowledge leaders at the company's helm provide access to decades of expertise in traditional sciences such as ecology, microbiology, infectious diseases, and genetics. Microbiome Insights' award-winning team is committed to providing clients with fast, dependable, cost-effective results.

CuePath is a healthcare technology company on a mission to help seniors and other vulnerable individuals stay healthy and independent with the support of their circle of care. The company aims to provide caregivers with the information needed to support users with medication adherence. CuePath Innovation designs smart medication packaging for seniors and provides a service that enables families to ensure that their senior family members stay on track with medications via mobile devices.

Augurex Life Sciences is a biotechnology company based in Vancouver, focused on developing biomarkers to enhance patient clinical management and improve disease outcomes. The company specializes in proprietary blood tests that utilize point-of-care technology. These tests are designed to connect with disease-specific applications and electronic health records, allowing healthcare providers to personalize clinical decision-making and optimize patient management. By leveraging innovative biomarker research, Augurex aims to transform the way diseases are monitored and treated, ultimately leading to better health outcomes for patients.

Anandia Laboratories Inc. is a biotechnology company based in Vancouver, Canada, that specializes in the testing and development of cannabinoid products. Founded in 2014, Anandia focuses on providing analytical testing services, including assessments of potency, pesticides, microbes, and terpenes, primarily to licensed cannabis producers and patients. The company leverages its scientific expertise in cannabis genomics and modern plant breeding techniques to support customers in interpreting testing results and addressing any identified issues. As of August 2018, Anandia operates as a subsidiary of Aurora Cannabis Inc., enhancing its capabilities in the rapidly evolving cannabis industry.